Views: 10 Author: Site Editor Publish Time: 2024-04-16 Origin: Site
Boric acid is used in selected pharmaceutical formulations as a buffering agent, a tonicity-adjusting ingredient, or part of an antimicrobial preservative system. Its function depends on the formulation, concentration, and route of administration.
For buyers comparing inorganic chemical raw materials, understanding these applications also means checking the required grade, supporting documentation, and suitability for the intended manufacturing process.
Boric acid, also known as orthoboric acid, is a white crystalline solid with the chemical formula H₃BO₃. It is a weak acid and is available as crystals or powder.
| Property | Information |
|---|---|
| Chemical name | Boric acid |
| CAS number | 10043-35-3 |
| Molecular formula | H₃BO₃ |
| Molecular weight | 61.83 g/mol |
| Appearance | White crystals or crystalline powder |
These identity details do not establish pharmaceutical suitability. Industrial, laboratory, and pharmaceutical grades can have different specifications and documentation requirements.
Boric acid and borates are used in certain eye-care formulations to help control pH and adjust tonicity. Examples include some artificial tears, lubricating eye drops, and ophthalmic rinsing solutions.
In these products, boric acid may function as an excipient rather than the active ingredient responsible for treatment. Its presence does not mean that a product can treat an eye infection.
Ophthalmic products require appropriate formulation, manufacturing controls, and sterility assurance. Dissolving raw boric acid in water does not produce a finished eye-care medicine.
Boric acid can serve as an antimicrobial preservative in selected formulations. Its contribution must be evaluated within the complete formulation, including other ingredients, pH, packaging, and intended use.
Manufacturers should verify:
Compatibility with the active ingredient and other excipients.
Preservative effectiveness in the finished product.
Chemical and physical stability during storage.
Suitability for the intended route of administration.
The presence of boric acid alone does not establish a product’s shelf life or guarantee protection against all microorganisms.
Boric acid has a limited role in the management of certain vaginal infections. CDC guidance includes intravaginal boric acid as an option for selected recurrent non-albicans vulvovaginal candidiasis cases.
This should not be described as routine vaginal cleansing or general infection prevention. Diagnosis and treatment selection require medical guidance, and pregnancy requires separate clinical assessment.
Industrial raw material should not be used to prepare homemade treatments. Boric acid vaginal preparations must never be swallowed.
For pharmaceutical manufacturing, material selection should follow the intended application and the manufacturer’s approved specification.
Before purchasing, review:
Grade and applicable standard: Confirm any claimed pharmacopoeial compliance with supporting documents.
Certificate of Analysis: Check batch results against the agreed specification.
Impurity controls: Assess relevant impurities and any application-specific limits.
Traceability: Verify the manufacturer, batch identification, and supply documentation.
Manufacturing requirements: Determine whether additional microbiological or other controls are necessary.
A high assay value alone does not establish pharmaceutical grade. Pharmaceutical-grade material also should not automatically be described as sterile.
Boron-containing materials are studied in pharmaceutical research, but the exact compound and formulation must be identified. Results obtained with a particular borate system or another boron-containing compound should not be presented as established therapeutic benefits of ordinary boric acid.
Boric acid should not be presented as a universal disinfectant or sterilant for medical instruments.
Medical-device reprocessing requires validated cleaning, disinfection, or sterilization procedures appropriate to the device and its intended use. A raw material’s antimicrobial properties do not demonstrate that it can ensure instrument sterility.
Safe handling should follow the supplier’s Safety Data Sheet and the requirements of the intended application.
Keep containers closed and protect the material from contamination.
Follow the specified storage conditions.
Use appropriate protective equipment when handling powder.
Prevent accidental ingestion and unauthorized access.
Manage spills and waste according to applicable requirements.
For medicinal products, safety assessment must consider exposure, administration route, treatment duration, and patient population.
It can function as a buffering agent, a tonicity-adjusting ingredient, or an antimicrobial preservative in selected formulations.
Not necessarily. Some ophthalmic products list boric acid as an inactive ingredient. The product label identifies the active ingredient and intended use.
Industrial-grade material should not be assumed suitable. Pharmaceutical manufacturing requires material that meets the approved specification and relevant quality requirements.
No. Sterility requires an appropriate manufacturing and control strategy. Adding boric acid does not establish sterility.
For boric acid sourcing enquiries, contact Aozun Chemical with your intended application, required grade, specification, quantity, and destination market. Confirm grade availability and supporting documentation before placing an order.